OMBLASTYS (OMBURTAMAB)

Live / Registered — Registered (as of 04 May 2021)

What this means for you

Registered since 04 May 2021. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
88886712
Registration number
6338259
Mark type
Design + words
Filed
24 Apr 2020
Published for opposition
16 Feb 2021
Registered
04 May 2021
Attorney of record
Andrew N. Spivak

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations and substances for the prevention of cancer
  • Class 042 — Scientific and technological services: Research and development services in the field of antibodies; research and development services in the field of antibody technology; laboratory research and analysis services relating to the production of antibodies; scientific and technological services, namely, scientific research, analysis, and testing in the field of antibodies, and research and design relating thereto; industrial analysis and research services in the field of antibodies

Owner

Prosecution history

  • 04 May 2021 — REGISTERED-PRINCIPAL REGISTER
  • 16 Feb 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 16 Feb 2021 — PUBLISHED FOR OPPOSITION
  • 27 Jan 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 27 Aug 2020 — ELECTRONIC RECORD REVIEW COMPLETE
  • 21 Aug 2020 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
  • 20 Aug 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 20 Aug 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 20 Aug 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 17 Aug 2020 — ASSIGNED TO LIE
  • 29 Jul 2020 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
  • 24 Jul 2020 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
  • 24 Jul 2020 — LETTER OF SUSPENSION E-MAILED
  • 24 Jul 2020 — SUSPENSION LETTER WRITTEN
  • 20 Jul 2020 — EXAMINER'S AMENDMENT ENTERED

View this trademark record on Marksy